-
NUMBER OF INSIDER BUYING
(Last 12 Months)
0 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
9 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$0 -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$2.11 M
Travere Therapeutics, Inc. Insider Transactions
Travere Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
LYONS GARY A
Director |
Sell | 21,179 @ $14.35 | $303,874 | 69,821 | 10/04/2024 | 10/04/2024 | |
|
LYONS GARY A
Director |
Sell | 18,821 @ $15.15 | $285,227 | 51,000 | 10/04/2024 | 10/04/2024 | |
|
Meckler Jeffrey A
Director |
Sell | 40,000 @ $14.06 | $562,324 | 81,000 | 09/30/2024 | 09/30/2024 | |
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 684 @ $12.98 | $8,878 | 61,949 | 09/10/2024 | 09/10/2024 | |
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D |
Sell | 4,387 @ $11.52 | $50,538 | 84,455 | 09/09/2024 | 09/09/2024 | |
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY |
Sell | 4,387 @ $11.52 | $50,538 | 78,633 | 09/09/2024 | 09/09/2024 | |
|
Dube Eric M
Director, CHIEF EXECUTIVE OFFICER |
Sell | 21,125 @ $11.52 | $243,360 | 361,975 | 09/09/2024 | 09/09/2024 | |
|
Inrig Jula
CHIEF MEDICAL OFFICER |
Sell | 2,191 @ $11.52 | $25,240 | 62,633 | 09/09/2024 | 09/09/2024 | |
|
Heerma Peter
CHIEF COMMERCIAL OFFICER |
Sell | 2,191 @ $11.52 | $25,240 | 107,958 | 09/09/2024 | 09/09/2024 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 2,490 @ $11.52 | $28,685 | 74,595 | 09/09/2024 | 09/09/2024 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 514 @ $9.51 | $4,888 | 70,335 | 09/04/2024 | 09/05/2024 | |
|
Cline Christopher R.
CHIEF FINANCIAL OFFICER |
Sell | 54 @ $6.74 | $364 | 70,849 | 04/11/2024 | 04/12/2024 | |
|
Dube Eric M
Director, CHIEF EXECUTIVE OFFICER |
Sell | 9,106 @ $8.53 | $77,693 | 360,616 | 02/01/2024 | 02/02/2024 | |
|
Dube Eric M
Director, CHIEF EXECUTIVE OFFICER |
Sell | 10,016 @ $8.86 | $88,742 | 350,600 | 02/01/2024 | 02/02/2024 | |
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D |
Sell | 2,174 @ $8.53 | $18,548 | 83,310 | 02/01/2024 | 02/02/2024 | |
|
ROTE WILLIAM E.
SENIOR VICE PRESIDENT, R&D |
Sell | 2,590 @ $8.86 | $22,947 | 80,720 | 02/01/2024 | 02/02/2024 | |
|
Calvin Sandra
SVP, CHIEF ACCOUNTING OFFICER |
Sell | 2,820 @ $8.53 | $24,058 | 52,017 | 02/01/2024 | 02/02/2024 | |
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY |
Sell | 2,174 @ $8.53 | $18,548 | 78,860 | 02/01/2024 | 02/02/2024 | |
|
REED ELIZABETH E
SVP, GC & CORPORATE SECRETARY |
Sell | 2,590 @ $8.86 | $22,947 | 76,270 | 02/01/2024 | 02/02/2024 | |
|
Heerma Peter
CHIEF COMMERCIAL OFFICER |
Sell | 4,195 @ $8.53 | $35,789 | 99,503 | 02/01/2024 | 02/02/2024 |
Travere Therapeutics, Inc. Frequently Asked Questions
-
Who is on Travere Therapeutics, Inc.'s Insider Roster?
The list of insiders at Travere Therapeutics, Inc. includes Inrig Jula, Heerma Peter, Calvin Sandra, ROTE WILLIAM E., Cline Christopher R., Dube Eric M, REED ELIZABETH E, Meckler Jeffrey A, LYONS GARY A.
-
How much insider selling is happening at Travere Therapeutics, Inc.?
Insiders have sold a total of 177,508 Travere Therapeutics, Inc. shares in the last 12 months for a total of 2.11 M sold.
-
Which Travere Therapeutics, Inc. insiders have been selling company stock?
The following insiders have sold Travere Therapeutics, Inc. shares in the last 12 months: Inrig Jula ($76,313), Heerma Peter ($75,167), Calvin Sandra ($32,310), ROTE WILLIAM E. ($110,509), Cline Christopher R. ($74,244), Dube Eric M ($480,337), REED ELIZABETH E ($110,509), Meckler Jeffrey A ($562,324), LYONS GARY A ($589,101),